Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Absci Corp (ABSI)

Absci Corp (ABSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 454,224
  • Shares Outstanding, K 113,556
  • Annual Sales, $ 5,720 K
  • Annual Income, $ -110,570 K
  • EBIT $ -84 M
  • EBITDA $ -49 M
  • 60-Month Beta 2.18
  • Price/Sales 77.85
  • Price/Cash Flow N/A
  • Price/Book 2.00

Options Overview Details

View History
  • Implied Volatility 167.33% ( +93.86%)
  • Historical Volatility 55.41%
  • IV Percentile 88%
  • IV Rank 37.50%
  • IV High 383.11% on 09/12/24
  • IV Low 37.86% on 10/07/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 220
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 12,615
  • Open Int (30-Day) 12,071

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.19
  • Number of Estimates 4
  • High Estimate -0.18
  • Low Estimate -0.20
  • Prior Year -0.24
  • Growth Rate Est. (year over year) +20.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.68 +6.24%
on 10/10/24
4.40 -11.02%
on 10/28/24
+0.03 (+0.90%)
since 10/04/24
3-Month
3.36 +16.52%
on 09/10/24
4.60 -14.89%
on 08/26/24
+0.34 (+9.36%)
since 08/05/24
52-Week
1.18 +231.78%
on 11/10/23
6.72 -41.74%
on 04/09/24
+2.49 (+175.70%)
since 11/03/23

Most Recent Stories

More News
Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI

ABSI : 3.92 (-2.00%)
Absci to Participate in Upcoming Investor Conferences

ABSI : 3.92 (-2.00%)
Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

ABSI : 3.92 (-2.00%)
1 'Strong Buy' Penny Stock to Invest in AI Drug Development

Investors seeking AI-led drug development opportunities can consider this top-rated biotech stock under $5.

AZN : 65.58 (-8.19%)
ABSI : 3.92 (-2.00%)
AI and Biotech Developers Lead the Charge in the Next Healthcare Transformation

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group – Earlier this year, US President Joe Biden and his administration put out a new executive order on safe, secure, and...

AVAI : 0.3231 (-2.00%)
MYO : 3.85 (+0.52%)
PRCT : 97.80 (+0.75%)
ISRG : 515.61 (+1.61%)
ABSI : 3.92 (-2.00%)
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The popular growth investor keeps adding to some of her favorite falling stocks.

TEM : 43.08 (-12.97%)
BLDE : 3.61 (+0.56%)
ABSI : 3.92 (-2.00%)
1 'Strong Buy' Biotech Stock With 132% Upside Potential

Analysts expect this small-cap biotech stock to more than double in value as it integrates AI into its drug development process.

ABSI : 3.92 (-2.00%)
MS : 116.63 (+0.42%)
AZN : 65.58 (-8.19%)
ALM.E.DX : 8.980 (-0.70%)
3 AI-Driven Drug Stocks to Buy Before They Breakout

The pharma sector is expected to undergo a huge disruption, thanks to the impact of artificial intelligence. Here are three companies that Wall Street analysts think could benefit, based on their AI-driven...

NVDA : 138.92 (+2.11%)
GOOGL : 169.58 (+0.20%)
AMZN : 196.80 (+0.52%)
GS : 518.06 (+1.29%)
ABCL : 2.72 (-5.88%)
REGN : 823.02 (-0.70%)
MRNA : 53.12 (-0.78%)
LLY : 801.63 (-0.56%)
NVS : 108.70 (-1.65%)
SDGR : 18.20 (-0.22%)
BMY : 55.20 (-0.45%)
ABSI : 3.92 (-2.00%)
Absci Reports Second Quarter 2022 Financial Results and Business Update

Exceeded annual Active Program guidance with ten programs signed year-to-date Executed strategic reorganization to extend cash runway into late-2025 ...

ABSI : 3.92 (-2.00%)
Absci to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit Conference

VANCOUVER, Wash. and NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep...

ABSI : 3.92 (-2.00%)

Business Summary

Absci Corporation is the AI-powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. The company's Creation(TM) Platform involved in discovery of novel biotherapeutic drug candidates and generation of the cell lines to manufacture them in a single...

See More

Key Turning Points

3rd Resistance Point 4.29
2nd Resistance Point 4.16
1st Resistance Point 4.08
Last Price 3.92
1st Support Level 3.87
2nd Support Level 3.74
3rd Support Level 3.66

See More

52-Week High 6.72
Fibonacci 61.8% 4.60
Fibonacci 50% 3.95
Last Price 3.92
Fibonacci 38.2% 3.30
52-Week Low 1.18

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar